تقرير
أعرض في EDS

Dysphagia as an Initial Presentation of Acute Myeloid Leukemia: A Rare Presentation of Myeloid Sarcoma.

التفاصيل البيبلوغرافية
العنوان: Dysphagia as an Initial Presentation of Acute Myeloid Leukemia: A Rare Presentation of Myeloid Sarcoma.
المؤلفون: Mohamed Salih R; Internal Medicine, Harlem Hospital Center, New York City, USA., Olusoji R; Internal Medicine, Harlem Hospital Center, New York City, USA., Nwankwo C; Internal Medicine, Harlem Hospital Center, New York City, USA., Osei N; Internal Medicine, Harlem Hospital Center, New York City, USA., Kwentoh IP; Internal Medicine, Harlem Hospital Center, New York City, USA., Nwankwo OT; Internal Medicine, Harlem Hospital Center, New York City, USA.
المصدر: Cureus [Cureus] 2024 Jan 20; Vol. 16 (1), pp. e52624. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Myeloid sarcoma (MS) represents a unique clinical presentation of acute myeloid leukemia (AML). This report describes a case of MS in a 66-year-old man who presented with dysphagia, nausea, vomiting, anorexia, and fatigue. Generalized lymphadenopathy was noted on physical exam and confirmed by CT scans which also showed diffuse esophageal wall thickening. Axillary lymph node biopsy was positive for MS. Bone marrow biopsy confirmed AML with 88% blasts. The patient received induction chemotherapy with decitabine and venetoclax and was planned for four cycles of treatment over three months while monitoring the response.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2024, Mohamed Salih et al.)
References: Cancer. 1973 Apr;31(4):948-55. (PMID: 4513297)
J Pediatr Hematol Oncol. 2011 Oct;33(7):e330-2. (PMID: 21941137)
Am J Clin Pathol. 2015 Aug;144(2):219-39. (PMID: 26185307)
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. (PMID: 28342811)
Blood. 2011 Oct 6;118(14):3785-93. (PMID: 21795742)
Blood. 2012 Jun 21;119(25):6109-17. (PMID: 22553315)
J Med Primatol. 2017 Apr;46(2):42-47. (PMID: 28145579)
Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):174-177. (PMID: 32021572)
Blood. 2011 May 12;117(19):5019-32. (PMID: 21300984)
Ther Adv Hematol. 2011 Oct;2(5):309-16. (PMID: 23556098)
Diagn Pathol. 2007 Oct 31;2:42. (PMID: 17974004)
Indian J Med Res. 2020 Nov;152(Suppl 1):S206. (PMID: 35345209)
فهرسة مساهمة: Keywords: acute myeloid leukemia (aml); acute myeloid sarcoma; bone marrow biopsy; dysphagia; lymphadenopathy
تواريخ الأحداث: Date Created: 20240220 Latest Revision: 20240221
رمز التحديث: 20240221
مُعرف محوري في PubMed: PMC10876097
DOI: 10.7759/cureus.52624
PMID: 38374841
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.52624